{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:33Z","timestamp":1761630693621,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.annder.2014.06.011","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T08:30:13Z","timestamp":1407313813000},"page":"593-597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Lupus cutan\u00e9 subaigu induit par la cap\u00e9citabine\u00a0: un cas"],"prefix":"10.1016","volume":"141","author":[{"given":"J.","family":"Fongue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lardet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-P.","family":"Dicostanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Rouby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-R.","family":"Harl\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Chiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2014.06.011_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy","volume":"103","author":"Reed","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annder.2014.06.011_bib0010","first-page":"465","article-title":"A systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234\u00a0patients in Sweden","volume":"167","author":"Gr\u00f6nhagen","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0020","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.revmed.2008.04.021","article-title":"Dermatologic manifestations in lupus erythematosus","volume":"29","author":"Franc\u00e8s","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2014.06.011_bib0025","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0961203309103050","article-title":"Chemotherapy-induced subacute lupus erythematosus","volume":"18","author":"Guhl","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.annder.2014.06.011_bib0030","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archdermatol.2010.258","article-title":"Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy","volume":"146","author":"Funke","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0040","first-page":"818","article-title":"Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4\u00a0cases","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1346-8138.2007.00313.x","article-title":"Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA\/Ro antibody","volume":"34","author":"Adachi","year":"2007","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000083798","article-title":"Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases","volume":"210","author":"Fumal","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2014.06.011_bib0055","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaad.2007.06.040","article-title":"Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine","volume":"59","author":"Weger","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archdermatol.2008.619","article-title":"Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy","volume":"145","author":"Fernandes","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0065","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1111\/j.1365-2230.2009.03280.x","article-title":"Subacute cutaneous lupus erythematosus induced by capecitabine","volume":"34","author":"Floristan","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0070","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1200\/JCO.2011.35.0686","article-title":"Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil","volume":"29","author":"Almagro","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2014.06.011_bib0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1346-8138.2012.01646.x","article-title":"Subacute cutaneous lupus erythematosus after treatment with capecitabine","volume":"40","author":"Kindem","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0080","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamadermatol.2013.4957","article-title":"Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent","volume":"149","author":"Wiznia","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0085","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203309106176","article-title":"Drug-induced lupus: an update on its dermatologic aspects","volume":"18","author":"Marzano","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.annder.2014.06.011_bib0090","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1067\/mjd.2003.244","article-title":"Severe subacute cutaneous lupus erythematosus presenting with generalized erythroderma and bullae","volume":"48","author":"Mutasim","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.06.011_bib0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tox.2004.12.025","article-title":"Drug-induced lupus","volume":"209","author":"Rubin","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.annder.2014.06.011_bib0100","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJM197805252982101","article-title":"Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome","volume":"298","author":"Woosley","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2014.06.011_bib0105","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.7973636","article-title":"Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils","volume":"266","author":"Jiang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.annder.2014.06.011_bib0110","first-page":"746","article-title":"New concepts in the pathogenesis of drug-induced lupus","volume":"73","author":"Yung","year":"1995","journal-title":"Lab Invest"},{"key":"10.1016\/j.annder.2014.06.011_bib0115","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1073\/pnas.0610434104","article-title":"Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus","volume":"104","author":"Mazari","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.annder.2014.06.011_bib0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00403-008-0890-x","article-title":"Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation","volume":"301","author":"Sontheimer","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.annder.2014.06.011_bib0125","first-page":"627","article-title":"Antinuclear antibody-keratinocyte interactions in photosensitive cutaneous lupus erythematosus","volume":"14","author":"Furukawa","year":"1999","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.annder.2014.06.011_bib0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2249.2004.02458.x","article-title":"Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus","volume":"136","author":"Yoshimasu","year":"2004","journal-title":"Clin Exp Immunol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814004827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814004827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:02:08Z","timestamp":1758970928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963814004827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0151963814004827"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2014.06.011","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lupus cutan\u00e9 subaigu induit par la cap\u00e9citabine\u00a0: un cas","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2014.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}